Every 10-Q that Neogen Corp (NEOG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NEOG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NEOG filings page.
Neogen Corporation (NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, versus $209.2 million a year earlier, up 6.5%. Gross profit was $105.5 million, compared with $95.0 million, and gross margin was 47.4%, versus 45.4%. Net loss was $11.9 million, or $0.05 per share, compared with net income of $36.3 million, or $0.17 per share; the prior-year period included a $76.4 million gain on the sale of the Cleaners and Disinfectants business. Operating loss was $1.8 million, versus $16.1 million, and operating cash flow was $12.9 million, compared with $10.8 million.
Cash and cash equivalents were $172.0 million as of August 31, 2026. Neogen has a definitive agreement to sell its Genomics business to Zoetis for $160.0 million, subject to customary closing conditions and regulatory approvals; Australian and New Zealand reviews entered a second phase and are expected to conclude by the end of December 2026. A voluntary recall affects approximately 133,000 unexpired units, with full refunds offered. The FDA issued a Warning Letter on September 23, 2026, after inspection of the contract manufacturer’s facility and testing showed microbiological contamination. Neogen prepaid $20.0 million on its term loan in June 2026 and a further $10.0 million in September 2026; no required principal payments are due until the third quarter of fiscal 2029.
Neogen Corp (NEOG) reported transactional and control updates for the quarter ended August 31, 2025. The company recognized a $76,390 gain on the sale of a business, received $121,724 in cash at closing (net of cash divested) and may receive up to $3,500 in contingent earnout consideration tied to 12 months of post‑closing revenue performance. The company made debt actions including $51,500 of principal activity on a Revolving Facility, $45,000 of prepayments on the Term Loan (generating a $393 extinguishment loss) and repurchased $3,500 million of Senior Notes (generating a $41 extinguishment loss). Management is strengthening internal controls, hiring dedicated control personnel, implementing document retention, and providing COSO framework training. The filing notes potential impacts from the Pillar Two global minimum tax rules and a forecasted top‑up tax mechanism, but no material top‑up tax was forecasted for foreign subsidiaries for the quarter.